FR22C1003I2 - Vaccin contre des infections streptococciques base sur des proteines de recombinaison - Google Patents

Vaccin contre des infections streptococciques base sur des proteines de recombinaison

Info

Publication number
FR22C1003I2
FR22C1003I2 FR22C1003C FR22C1003C FR22C1003I2 FR 22C1003 I2 FR22C1003 I2 FR 22C1003I2 FR 22C1003 C FR22C1003 C FR 22C1003C FR 22C1003 C FR22C1003 C FR 22C1003C FR 22C1003 I2 FR22C1003 I2 FR 22C1003I2
Authority
FR
France
Prior art keywords
vaccine against
recombination proteins
streptococcal infections
against streptococcal
infections based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR22C1003C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervacc AB
Original Assignee
Intervacc AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervacc AB filed Critical Intervacc AB
Publication of FR22C1003I1 publication Critical patent/FR22C1003I1/fr
Application granted granted Critical
Publication of FR22C1003I2 publication Critical patent/FR22C1003I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR22C1003C 2010-05-26 2022-01-12 Vaccin contre des infections streptococciques base sur des proteines de recombinaison Active FR22C1003I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34837610P 2010-05-26 2010-05-26
PCT/SE2011/050652 WO2011149419A1 (fr) 2010-05-26 2011-05-25 Vaccin contre des infections streptococciques basé sur des protéines de recombinaison

Publications (2)

Publication Number Publication Date
FR22C1003I1 FR22C1003I1 (fr) 2022-02-18
FR22C1003I2 true FR22C1003I2 (fr) 2023-02-03

Family

ID=45004197

Family Applications (1)

Application Number Title Priority Date Filing Date
FR22C1003C Active FR22C1003I2 (fr) 2010-05-26 2022-01-12 Vaccin contre des infections streptococciques base sur des proteines de recombinaison

Country Status (10)

Country Link
US (2) US9333252B2 (fr)
EP (2) EP2590994B1 (fr)
CN (1) CN103068838B (fr)
AU (1) AU2011258898B2 (fr)
CA (1) CA2799136A1 (fr)
ES (2) ES2948841T3 (fr)
FR (1) FR22C1003I2 (fr)
HK (1) HK1183677A1 (fr)
NL (1) NL301156I2 (fr)
WO (1) WO2011149419A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2498812A4 (fr) * 2009-11-13 2013-05-22 Bengt Guss Composition d'immunisation pour réduire des infections streptococciques
EP2949340A1 (fr) * 2014-05-30 2015-12-02 IDT Biologika GmbH Composition de vaccin contre l'infection par Streptococcus suis
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
CN104789587B (zh) * 2015-04-10 2018-04-27 新疆农业大学 重组真核表达质粒复合物在制备马腺疫链球菌疫苗的应用
EP4169934A1 (fr) * 2020-06-18 2023-04-26 Shanghai Bao Pharmaceuticals Co., Ltd. Mutant d'enzyme de dégradation d'immunoglobuline idee
CN112011479B (zh) * 2020-08-06 2022-04-22 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种hlj2018d-lx株及其在制备马链球菌马亚种灭活疫苗中的应用
CN114437235B (zh) * 2022-01-04 2024-02-09 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用
WO2024112492A1 (fr) * 2022-11-22 2024-05-30 Duke University Compositions comprenant des enzymes de clivage d'anticorps et leur procédé d'utilisation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241545A1 (es) 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US5583014A (en) 1990-07-03 1996-12-10 Bayer Corporation Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine
SE9302855D0 (sv) 1993-09-06 1993-09-06 Martin Lindberg Method and means for producing plasmaproteinase inhibitor binding proteins
IES76925B2 (en) 1996-07-03 1997-11-19 Provost Subunit Vaccine for Streptococcus Equi
FR2750999B1 (fr) 1996-07-10 1998-11-20 Appligene Oncor Adn polymerase thermostable d'archaebacteries du genre pyrococcus sp
SE9804491D0 (sv) 1998-12-22 1998-12-22 Bengt Guss Novel fibronectin-binding protein
CA2501621C (fr) * 2002-10-11 2012-01-24 Bengt Guss Immunisation de mammiferes non humains contre streptococcus equi
EP2759307B1 (fr) 2006-03-29 2016-11-09 Merial Limited Vaccin contre des streptocoques
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
EP2190984B1 (fr) 2007-09-14 2013-09-04 Genovis Ab Procédé et trousses de purification et de détection d'IgG glycosylée
US20110020403A1 (en) 2007-12-13 2011-01-27 Bengt Guss immunizing composition
GB0801326D0 (en) 2008-01-24 2008-03-05 Animal Health Trust Vaccines
AU2010204139A1 (en) * 2009-01-12 2011-08-11 Novartis Ag Cna_B domain antigens in vaccines against gram positive bacteria
EP2498812A4 (fr) 2009-11-13 2013-05-22 Bengt Guss Composition d'immunisation pour réduire des infections streptococciques

Also Published As

Publication number Publication date
ES2948841T3 (es) 2023-09-20
ES2612520T3 (es) 2017-05-17
AU2011258898A1 (en) 2012-11-29
AU2011258898B2 (en) 2015-05-07
EP2590994A1 (fr) 2013-05-15
EP3135684B1 (fr) 2023-06-28
US9795664B2 (en) 2017-10-24
US20160082096A1 (en) 2016-03-24
WO2011149419A1 (fr) 2011-12-01
EP3135684C0 (fr) 2023-06-28
HK1183677A1 (zh) 2014-01-03
EP2590994B1 (fr) 2016-11-02
CA2799136A1 (fr) 2011-12-01
CN103068838A (zh) 2013-04-24
FR22C1003I1 (fr) 2022-02-18
NL301156I2 (nl) 2022-03-11
EP3135684A1 (fr) 2017-03-01
CN103068838B (zh) 2016-03-02
US9333252B2 (en) 2016-05-10
US20130236469A1 (en) 2013-09-12
EP2590994A4 (fr) 2014-04-30

Similar Documents

Publication Publication Date Title
FR22C1003I2 (fr) Vaccin contre des infections streptococciques base sur des proteines de recombinaison
SMT201600049B (it) Formulazioni di apixaban
DK3170508T3 (da) Vaccineformuleringer
BRPI0911604A2 (pt) vacinas de polipeptídeo de flagelina
BR112014009050A2 (pt) pirrolbenzodiazepinas e conjugados destas
DK3459564T3 (da) Plasmakallikreinbindende proteiner
BR112013012195A2 (pt) oligonucleotídeo imunoestimulatórios
DK2528621T3 (da) Modificerede tuberkuloseantigener
BR112013013427A2 (pt) vaso
BR112013020383A2 (pt) formulações liofilizadas.
DE102012205562A8 (de) Lufteinlassvorrichtung
DK2640598T3 (da) Strækningsisolator
BR112014005756A2 (pt) vacina
IT1402213B1 (it) Estensione per capelli
BR112013006017A2 (pt) pneumático
BR112013002687A2 (pt) pneumático
IT1399860B1 (it) Fermaglio per capelli
IT1404372B1 (it) Piccozza regolabile
EP2786145A4 (fr) Conjugués de peptide mélittine et procédés les utilisant
BR112013009679A2 (pt) peptídeo
BR112013015582A2 (pt) pneumático
BR112013024404A2 (pt) repelente com base em piretrina
BRDI7102905S (pt) Configuração aplicada em pneumático
BR112013022164A2 (pt) peptídeo, vacina, e, anticorpo
DE102010002918A8 (de) Briefkastenanlage